Nanopublications LDF server

Matches in Nanopublications for { ?s ?p "[Arginase 2, inducible- and endothelial-nitric-oxide synthase (iNOS and eNOS), indoleamine 2,3-dioxygenase (IDO) and TGF-beta, might impair immune functions in prostate cancer (PCA) patients.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }

• assertion description "[Arginase 2, inducible- and endothelial-nitric-oxide synthase (iNOS and eNOS), indoleamine 2,3-dioxygenase (IDO) and TGF-beta, might impair immune functions in prostate cancer (PCA) patients.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[Arginase 2, inducible- and endothelial-nitric-oxide synthase (iNOS and eNOS), indoleamine 2,3-dioxygenase (IDO) and TGF-beta, might impair immune functions in prostate cancer (PCA) patients.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[Arginase 2, inducible- and endothelial-nitric-oxide synthase (iNOS and eNOS), indoleamine 2,3-dioxygenase (IDO) and TGF-beta, might impair immune functions in prostate cancer (PCA) patients.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• NP435748.RAIs22wiFuyhVyjLXxpsKsZfNN5k4_ww2RpPHvvsb-KeA130_assertion description "[Arginase 2, inducible- and endothelial-nitric-oxide synthase (iNOS and eNOS), indoleamine 2,3-dioxygenase (IDO) and TGF-beta, might impair immune functions in prostate cancer (PCA) patients.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP435748.RAIs22wiFuyhVyjLXxpsKsZfNN5k4_ww2RpPHvvsb-KeA130_provenance.
• NP251962.RASGLzjv1E8CbW7fnXwMj2Wm20NckSWDqvXOFtVMEseyY130_assertion description "[Arginase 2, inducible- and endothelial-nitric-oxide synthase (iNOS and eNOS), indoleamine 2,3-dioxygenase (IDO) and TGF-beta, might impair immune functions in prostate cancer (PCA) patients.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP251962.RASGLzjv1E8CbW7fnXwMj2Wm20NckSWDqvXOFtVMEseyY130_provenance.
• NP594733.RAf9SFm7Uu1CzQg1WdOc4OCfeXHV46-RKbHp0GDDOi_l8130_assertion description "[Arginase 2, inducible- and endothelial-nitric-oxide synthase (iNOS and eNOS), indoleamine 2,3-dioxygenase (IDO) and TGF-beta, might impair immune functions in prostate cancer (PCA) patients.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP594733.RAf9SFm7Uu1CzQg1WdOc4OCfeXHV46-RKbHp0GDDOi_l8130_provenance.
• NP594804.RAVbkFipT3T9WOWK6iyENeC5fa7LI3QyYXtFMzSMJ0WLc130_assertion description "[Arginase 2, inducible- and endothelial-nitric-oxide synthase (iNOS and eNOS), indoleamine 2,3-dioxygenase (IDO) and TGF-beta, might impair immune functions in prostate cancer (PCA) patients.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP594804.RAVbkFipT3T9WOWK6iyENeC5fa7LI3QyYXtFMzSMJ0WLc130_provenance.
• assertion description "[Arginase 2, inducible- and endothelial-nitric-oxide synthase (iNOS and eNOS), indoleamine 2,3-dioxygenase (IDO) and TGF-beta, might impair immune functions in prostate cancer (PCA) patients.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[Arginase 2, inducible- and endothelial-nitric-oxide synthase (iNOS and eNOS), indoleamine 2,3-dioxygenase (IDO) and TGF-beta, might impair immune functions in prostate cancer (PCA) patients.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[Arginase 2, inducible- and endothelial-nitric-oxide synthase (iNOS and eNOS), indoleamine 2,3-dioxygenase (IDO) and TGF-beta, might impair immune functions in prostate cancer (PCA) patients.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• NP681599.RADnhqFyS0hpDCn2EYlT-Oz_BVrBJhAqh4QHZIjzMiiwI130_assertion description "[Arginase 2, inducible- and endothelial-nitric-oxide synthase (iNOS and eNOS), indoleamine 2,3-dioxygenase (IDO) and TGF-beta, might impair immune functions in prostate cancer (PCA) patients.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP681599.RADnhqFyS0hpDCn2EYlT-Oz_BVrBJhAqh4QHZIjzMiiwI130_provenance.
• NP681594.RAUf7fwMypz6AFiLBrxmMmpcrO6zk8p_xf1m0CETZpxMA130_assertion description "[Arginase 2, inducible- and endothelial-nitric-oxide synthase (iNOS and eNOS), indoleamine 2,3-dioxygenase (IDO) and TGF-beta, might impair immune functions in prostate cancer (PCA) patients.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP681594.RAUf7fwMypz6AFiLBrxmMmpcrO6zk8p_xf1m0CETZpxMA130_provenance.
• NP251956.RACuxTyzprID_bhFJI0mH6DY4Gp9SiYj77QkPpVuOPeOo130_assertion description "[Arginase 2, inducible- and endothelial-nitric-oxide synthase (iNOS and eNOS), indoleamine 2,3-dioxygenase (IDO) and TGF-beta, might impair immune functions in prostate cancer (PCA) patients.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP251956.RACuxTyzprID_bhFJI0mH6DY4Gp9SiYj77QkPpVuOPeOo130_provenance.
• NP681595.RAimdOsT04SzL7YNEjeW8zXOaHSovL3BtvS7oPk1_cc_c130_assertion description "[Arginase 2, inducible- and endothelial-nitric-oxide synthase (iNOS and eNOS), indoleamine 2,3-dioxygenase (IDO) and TGF-beta, might impair immune functions in prostate cancer (PCA) patients.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP681595.RAimdOsT04SzL7YNEjeW8zXOaHSovL3BtvS7oPk1_cc_c130_provenance.
• NP681598.RAmY5l1rzufiQLYpN33agBkhTu4iaUp9F3wdhTktY6bzY130_assertion description "[Arginase 2, inducible- and endothelial-nitric-oxide synthase (iNOS and eNOS), indoleamine 2,3-dioxygenase (IDO) and TGF-beta, might impair immune functions in prostate cancer (PCA) patients.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP681598.RAmY5l1rzufiQLYpN33agBkhTu4iaUp9F3wdhTktY6bzY130_provenance.